Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Sep;107(1):161–164. doi: 10.1111/j.1476-5381.1992.tb14480.x

H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450.

F S LaBella 1, G Queen 1, G Glavin 1, G Durant 1, D Stein 1, L J Brandes 1
PMCID: PMC1907623  PMID: 1330158

Abstract

1. Thioperamide (TP), an imidazole and a highly potent, specific antagonist of the histamine H3 receptor, inhibited the secretion of cortisol from bovine isolated adrenocortical cells (IC50 0.20 microM) and in the rat (5 mg kg-1) prevented both basal and stress-induced secretion of corticosterone. 2. In adrenocortical microsomes, low affinity binding of [3H]-histamine (KD 27.7 microM) was potently inhibited by TP (Ki 0.33 microM). 3. In adrenocortical microsomal membranes, both histamine and TP yielded type II difference absorption spectra, characteristic of the interaction between imidazole and cytochrome P450 enzymes. Dissociation constants for binding to P450, calculated from spectral data, were 15.9 microM and 1.5 mM for histamine, and 0.3 microM and 3.7 microM for TP. 4. In view of previously reported evidence for an intracellular mediator role of histamine in platelets, the present findings suggest a physiological role for histamine in the modulation of adrenal P450 monooxygenases that generate adrenocortical steroids. 5. The results suggest that direct adrenocortical inhibition by thioperamide at a non-H3 intracellular site must be taken into account in studies designed to elucidate functional roles of H3 receptors.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrang J. M., Garbarg M., Lancelot J. C., Lecomte J. M., Pollard H., Robba M., Schunack W., Schwartz J. C. Highly potent and selective ligands for histamine H3-receptors. Nature. 1987 May 14;327(6118):117–123. doi: 10.1038/327117a0. [DOI] [PubMed] [Google Scholar]
  2. Ayub M., Levell M. J. Inhibition of human adrenal steroidogenic enzymes in vitro by imidazole drugs including ketoconazole. J Steroid Biochem. 1989 Apr;32(4):515–524. doi: 10.1016/0022-4731(89)90384-1. [DOI] [PubMed] [Google Scholar]
  3. Backes W. L., Canady W. J. Methods for the evaluation of hydrophobic substrate binding to cytochrome P-450. Pharmacol Ther. 1981;12(1):133–158. doi: 10.1016/0163-7258(81)90078-4. [DOI] [PubMed] [Google Scholar]
  4. Boobis A. R., Brodie M. J., Kahn G. C., Fletcher D. R., Saunders J. H., Davies D. S. Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol. 1980 Jan;9(1):11–19. doi: 10.1111/j.1365-2125.1980.tb04790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brandes L. J., Bogdanovic R. P., Cawker M. D., LaBella F. S. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels. Cancer Res. 1987 Aug 1;47(15):4025–4031. [PubMed] [Google Scholar]
  6. Brandes L. J., Davie J. R., Paraskevas F., Sukhu B., Bogdanovic R. P., LaBella F. S. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver. Agents Actions Suppl. 1991;33:325–342. doi: 10.1007/978-3-0348-7309-3_24. [DOI] [PubMed] [Google Scholar]
  7. Brandes L. J., LaBella F. S., Glavin G. B., Paraskevas F., Saxena S. P., McNicol A., Gerrard J. M. Histamine as an intracellular messenger. Biochem Pharmacol. 1990 Oct 15;40(8):1677–1681. doi: 10.1016/0006-2952(90)90341-h. [DOI] [PubMed] [Google Scholar]
  8. Brandes L. J., LaBella F. S. Histamine and calcium are independently regulated intracellular mediators of lymphocyte mitogenesis. Biochem Biophys Res Commun. 1992 Jan 31;182(2):786–793. doi: 10.1016/0006-291x(92)91801-v. [DOI] [PubMed] [Google Scholar]
  9. Estabrook R. W., Werringloer J. The measurement of difference spectra: application to the cytochromes of microsomes. Methods Enzymol. 1978;52:212–220. doi: 10.1016/s0076-6879(78)52024-7. [DOI] [PubMed] [Google Scholar]
  10. Feldman D. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev. 1986 Nov;7(4):409–420. doi: 10.1210/edrv-7-4-409. [DOI] [PubMed] [Google Scholar]
  11. Jefcoate C. R. Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy. Methods Enzymol. 1978;52:258–279. doi: 10.1016/s0076-6879(78)52029-6. [DOI] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lennard M. S., Crewe H. K., Tucker G. T., Woods H. F. Histamine: an inhibitor of cytochrome P-450-catalysed drug metabolism. Biochem Pharmacol. 1986 Aug 1;35(15):2459–2460. doi: 10.1016/0006-2952(86)90040-7. [DOI] [PubMed] [Google Scholar]
  14. Li Z. G., Park D., LaBella F. S. Adrenocorticotropin(1-10) and -(11-24) promote adrenal steroidogenesis by different mechanisms. Endocrinology. 1989 Aug;125(2):592–596. doi: 10.1210/endo-125-2-592. [DOI] [PubMed] [Google Scholar]
  15. Morris C. Q., Tucker G. T., Crewe H. K., Harlow J. R., Woods H. F., Lennard M. S. Histamine inhibition of mixed function oxidase activity in rat and human liver microsomes and in the isolated perfused rat liver. Biochem Pharmacol. 1989 Aug 15;38(16):2639–2644. doi: 10.1016/0006-2952(89)90549-2. [DOI] [PubMed] [Google Scholar]
  16. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  17. Murray M. Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents. Drug Metab Rev. 1987;18(1):55–81. doi: 10.3109/03602538708998300. [DOI] [PubMed] [Google Scholar]
  18. Parnham M. J., Bragt P. C., Bast A., Zijlstra F. J. Comparison of the effects of inhibitors of cytochrome P-450-mediated reactions on human platelet aggregation and arachidonic acid metabolism. Biochim Biophys Acta. 1981 Oct 12;677(2):165–173. doi: 10.1016/0304-4165(81)90081-7. [DOI] [PubMed] [Google Scholar]
  19. Saxena S. P., Brandes L. J., Becker A. B., Simons K. J., LaBella F. S., Gerrard J. M. Histamine is an intracellular messenger mediating platelet aggregation. Science. 1989 Mar 24;243(4898):1596–1599. doi: 10.1126/science.2928797. [DOI] [PubMed] [Google Scholar]
  20. Schunack W. Histaminähnliche Verbindungen mit cyclisierter Seitenkette. 1. Uber Struktur-Wirkungs-Beziehungen bei Histaminanaloga. Arch Pharm (Weinheim) 1973 Dec;306(12):934–942. doi: 10.1002/ardp.19733061208. [DOI] [PubMed] [Google Scholar]
  21. Testa B., Jenner P. Inhibitors of Cytochrome P-450s and their mechanism of action. Drug Metab Rev. 1981;12(1):1–117. doi: 10.3109/03602538109011082. [DOI] [PubMed] [Google Scholar]
  22. van der VIES Individual determination of cortisol and corticosterone in a single small sample of peripheral blood. Acta Endocrinol (Copenh) 1961 Nov;38:399–406. doi: 10.1530/acta.0.0380399. [DOI] [PubMed] [Google Scholar]
  23. van der Werf J. F., Timmerman H. The histamine H3 receptor: a general presynaptic histaminergic regulatory system? Trends Pharmacol Sci. 1989 Apr;10(4):159–162. doi: 10.1016/0165-6147(89)90169-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES